be_ixf;ym_202512 d_19; ct_50
NYSE:KO charts & data provided by TradingView

Latest Insights on KO

The market is going to the moon in 2020 … well, at least halfway, according to Piper Jaffray. Go Bull or Bust; Netflix Is Mr. Worldwide December 17, 2019 by Joseph Hargett Great Stuff Go Bull or Go Broke Now that we have some semblance of a trade deal with China — or an anti-tariff deal, as I like to call it — we can truly focus on the case for a bull market in 2020. Yes, Great Stuff — your occasional harbinger of market doom — is looking […]
A popular topic is whether stocks are already in a melt-up today. To find out the real answer, let’s take a look at an important chart. The Next Melt-Up: Is It Already Here? December 16, 2019 by Michael Carr Stocks, Winning Investor Daily A popular topic is whether stocks are already in a melt-up today. To find out the real answer, let’s take a look at an important chart.
This week, our experts gave their predictions for 2020. It was an insightful — and surprising — look ahead at what to expect next year. Our Experts’ Biggest, Boldest Predictions for 2020 December 14, 2019 by Jay Goldberg Trending, Winning Investor Daily This week, our experts gave their predictions for 2020. It was an insightful — and surprising — look ahead at what to expect next year.
Tesla Cybertruck Why Tesla’s Cybertruck Will Ignite a Rally in This Precious Metal December 13, 2019 by Anthony Planas American Investor Today, Precious Metals Increased demand for silver in electric vehicles (EVs) — and a recent pullback in silver prices — sets up a rally for the precious metal. Anthony takes a look at an exchange-traded fund that has outperformed silver this year. Then, he shares a way to play silver’s rise in 2020 before EVs begin to strain supplies.
Biotech stocks are naturally speculative. You don’t want to use your lunch money to buy them. But they can deliver life-changing gains. 2 Biotech Stocks to Grab Before Their 2020 Breakout December 12, 2019 by Brian Christopher Investment Opportunities, Technology, Winning Investor Daily Biotech stocks are naturally speculative. You don’t want to use your lunch money to buy them. But they can deliver life-changing gains.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Looks like I have finally found the right person to learn and grow from.”

- James

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

Share This